NovoCure Limited (NVCR)

NASDAQ: NVCR · Real-Time Price · USD

13.04

-1.19 (-8.36%)

At close: Mar 6, 2026, 4:00 PM EST

13.00

-0.04 (-0.30%)

After-hours: Mar 6, 2026, 7:42 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Tumor Treating Fields (TTFields)	655.35M	605.22M	509.34M	537.84M	535.03M
Tumor Treating Fields (TTFields) Growth	8.28%	18.82%	-5.30%	0.53%	8.23%
Total	655.35M	605.22M	509.34M	537.84M	535.03M
Total Growth	8.28%	18.82%	-5.30%	0.53%	8.23%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	385.63M	391.80M	349.74M	406.89M	353.11M
United States Growth	-1.57%	12.03%	-14.05%	15.23%	3.62%
Germany	79.41M	65.26M	60.21M	46.12M	93.94M
Germany Growth	21.67%	8.39%	30.55%	-50.90%	0.72%
France	76.19M	55.73M	11.74M	-	-
France Growth	36.71%	374.86%	-	-	-
Japan	37.79M	32.57M	31.67M	32.78M	34.64M
Japan Growth	16.02%	2.85%	-3.40%	-5.37%	19.14%
Other International Markets	56.90M	42.47M	32.76M	30.71M	30.58M
Other International Markets Growth	33.97%	29.65%	6.66%	0.44%	-
Greater China	19.44M	17.39M	23.22M	21.33M	22.77M
Greater China Growth	11.82%	-25.14%	8.87%	-6.29%	80.82%
Total	655.35M	605.22M	509.34M	537.84M	535.03M
Total Growth	8.28%	18.82%	-5.30%	0.53%	8.23%

Source: S&P Global Market Intelligence.